GRCE GRACE THERAPEUTICS INC Management Changes 8-K Filing 2024 - Annual Meeting Results Acasti Pharma Inc. held its Annual Meeting on September 30, 2024, where shareholders approved several proposals including the 2024 Equity Incentive Plan and the appointment of KPMG as the independent auditor, with 70.50% of shares represented at the meeting.Get access to all SEC 8-K filings of the GRACE THERAPEUTICS INC